1/19/2023 12:00:00 AM Macfarlanes advises SV Health Investors on launch of its SV Biotech Crossover Opportunities Fund By Stephen Robinson Miriam Cable Mark Baldwin Macfarlanes has advised SV Health Investors on its latest fund SV Biotech Crossover Opportunities Fund (SV BCOF). The fund has received...
1/17/2023 12:00:00 AM Macfarlanes advises CHC Helicopter on the sale of Offshore Helicopter Services UK to Ultimate Aviation By Tom Rose Christophe Humpe Martha Campbell Macfarlanes is advising CHC Helicopter Group, the global helicopter company specialising in transportation and search and rescue...
1/16/2023 12:00:00 AM Macfarlanes advises BMS Group on investment from Eurazeo By Stephen Drewitt Adam Campbell Felicity Powell Macfarlanes has advised independent speciality insurance and reinsurance broker BMS Group on an agreement with Eurazeo for an additional...
1/13/2023 12:00:00 AM Macfarlanes advises Isio in connection with its proposed acquisition of Deloitte UK’s pensions business By Kirstie Hutchinson Stephen Pike Macfarlanes has advised Isio on the debt financing, management equity and management employment arrangements in connection with Isio’s...
1/12/2023 12:00:00 AM Macfarlanes advises on Supermarket Income REIT’s acquisition of an additional stake in a joint venture By Mark Slade Macfarlanes has advised Supermarket Income REIT, the real estate investment trust providing secure, inflation-protected, long income from...
1/11/2023 12:00:00 AM Macfarlanes advises Tulchan on sale to Teneo By Stephen Pike Stephen Drewitt Kathryn Jarvis-Hunter Macfarlanes has advised Tulchan, a leading independent M&A, financial and corporate communications advisory firm, on its sale to Teneo, a...
1/4/2023 12:00:00 AM Macfarlanes advises Valderrama Limited on proposed acquisition of Dignity plc. By Harry Coghill Max Mittasch Mark Slade Macfarlanes is advising Valderrama Limited, a joint venture company controlled by SPWOne V Limited and Castelnau Group Limited (whose...